Halozyme Therapeutics, Inc. ranks near the peer group median, with growth as the main structural strength, while stability is less supportive than the other dimensions.
Growth Premium With Volatility Risk
52w drawdown 0.0% · 21d vs sector +33.8%
Peer-relative scores, weakest to strongest
Halozyme Therapeutics develops drug delivery technologies and forms partnerships with major pharmaceutical companies.
HALO is priced as a platform play with a growth premium. Because HALO relies on ENHANZE® partner-driven growth, the market interprets every revenue trend as a platform signal—so even small deviations in growth are met with outsized price reactions, as reflected in the 46.2% one-year volatility. HALO differentiates itself through technology partnerships with leading pharma companies, which increases the expectation for consistently high revenue growth—38% projected for 2025, well above the peer median. The market treats HALO as a structural outperformer and assigns a valuation premium accordingly. When HALO reports a single weak growth quarter, the market quickly compresses the premium, leading to sharp repricing.
Break down HALO's position across all dimensions with the full interactive tool.
This analysis is rule-based and descriptive. Peer-relative scores are derived from functional peer group comparisons using publicly available financial data. Scores reflect structural positioning only and do not constitute investment advice, a buy or sell recommendation, or a forecast of future performance. AssetNext peer scores are recalculated periodically as new data becomes available.
AssetNext scores reflect each company's structural position within its functional peer group — not a ranking against all stocks simultaneously. Peers are identified by similarity across eight financial dimensions, including revenue growth trajectory, margin structure, capital intensity, and earnings stability. A score of 75 means the company ranks in the top quartile within its own peer group, not the entire market.
Four dimension scores drive the overall peer score: Growth (revenue trajectory and expansion dynamics), Quality (margin structure and capital efficiency), Valuation (peer-relative pricing on standard multiples), and Stability (earnings consistency and financial predictability). Each dimension is scored 0–100 relative to the peer group, then combined into an overall peer score using equal weighting.
Because scores are peer-relative, the same company can have slightly different scores in different index universes. On comparison pages, both companies are shown within their shared peer universe wherever possible — so the scores are directly comparable. The peer basis is stated on each score card.
Scores are recalculated periodically as underlying financial data is updated. All analysis is descriptive and rule-based — AssetNext describes structural realities and never issues buy, sell or hold recommendations.